Dapsone and schistocytes: Thrombotic microangiopathy or not?

Alexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot · 2026

Read Dapsone and schistocytes: Thrombotic microangiopathy or not? by Alexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13196926.txt.

Description

Alexis Archambeaud and colleagues published a 2026 review of past cases on dapsone and red cell damage. Dapsone is a drug used for leprosy and some skin and immune diseases. It can break down red blood cells, yet broken cell fragments called schistocytes are not expected in that process.

The team reviewed adults treated at one French hospital over sixteen years. Of 19 patients with blood smear tests, ten had schistocytes in their blood. Those patients had sharper drops in blood counts and stronger signs of cell breakdown. No organ failure was found in the records. The fragments cleared within days once the drug stopped. Whether this pattern can harm organs needs more study.

Catalog record

CREATORAlexis Archambeaud, Cédric Aumont, Claire Pouplard, Marie-Sarah Agier, François Maillot, Jean-Michel Halimi, Adrien Bigot
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13196926

Browse the full library · About the Tower of Babel